The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback